ACRV
Price
$2.44
Change
+$0.05 (+2.09%)
Updated
Dec 26 closing price
Capitalization
76.99M
89 days until earnings call
Intraday BUY SELL Signals
CRBU
Price
$1.70
Change
-$0.02 (-1.16%)
Updated
Dec 26 closing price
Capitalization
158.9M
79 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACRV vs CRBU

Header iconACRV vs CRBU Comparison
Open Charts ACRV vs CRBUBanner chart's image
Acrivon Therapeutics
Price$2.44
Change+$0.05 (+2.09%)
Volume$181.13K
Capitalization76.99M
Caribou Biosciences
Price$1.70
Change-$0.02 (-1.16%)
Volume$780.17K
Capitalization158.9M
ACRV vs CRBU Comparison Chart in %
ACRV
Daily Signal:
Gain/Loss:
CRBU
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ACRV vs. CRBU commentary
Dec 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRV is a StrongBuy and CRBU is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 28, 2025
Stock price -- (ACRV: $2.44 vs. CRBU: $1.70)
Brand notoriety: ACRV and CRBU are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACRV: 23% vs. CRBU: 29%
Market capitalization -- ACRV: $76.99M vs. CRBU: $158.9M
ACRV [@Biotechnology] is valued at $76.99M. CRBU’s [@Biotechnology] market capitalization is $158.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACRV’s FA Score shows that 1 FA rating(s) are green whileCRBU’s FA Score has 1 green FA rating(s).

  • ACRV’s FA Score: 1 green, 4 red.
  • CRBU’s FA Score: 1 green, 4 red.
According to our system of comparison, ACRV is a better buy in the long-term than CRBU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACRV’s TA Score shows that 4 TA indicator(s) are bullish while CRBU’s TA Score has 5 bullish TA indicator(s).

  • ACRV’s TA Score: 4 bullish, 4 bearish.
  • CRBU’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, CRBU is a better buy in the short-term than ACRV.

Price Growth

ACRV (@Biotechnology) experienced а +12.96% price change this week, while CRBU (@Biotechnology) price change was +1.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.36%. For the same industry, the average monthly price growth was +0.27%, and the average quarterly price growth was +54.56%.

Reported Earning Dates

ACRV is expected to report earnings on Mar 26, 2026.

CRBU is expected to report earnings on Mar 16, 2026.

Industries' Descriptions

@Biotechnology (+0.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRBU($159M) has a higher market cap than ACRV($77M). CRBU YTD gains are higher at: 6.918 vs. ACRV (-59.468). ACRV has higher annual earnings (EBITDA): -87.65M vs. CRBU (-142.47M). CRBU has more cash in the bank: 147M vs. ACRV (129M). ACRV has less debt than CRBU: ACRV (2.99M) vs CRBU (25.5M). CRBU has higher revenues than ACRV: CRBU (9.3M) vs ACRV (0).
ACRVCRBUACRV / CRBU
Capitalization77M159M48%
EBITDA-87.65M-142.47M62%
Gain YTD-59.4686.918-860%
P/E RatioN/AN/A-
Revenue09.3M-
Total Cash129M147M88%
Total Debt2.99M25.5M12%
TECHNICAL ANALYSIS
Technical Analysis
ACRVCRBU
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 9 days ago
86%
Bearish Trend 11 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
67%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ACRV
Daily Signal:
Gain/Loss:
CRBU
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SILDF5.09N/A
N/A
Sintokogio Ltd.
RENXF0.08N/A
N/A
Renalytix plc
CYTOF0.09N/A
N/A
Altamira Therapeutics Ltd.
THKLY13.05-0.21
-1.58%
THK Co., Ltd.
SGGEF14.00-0.72
-4.86%
Sage Group plc (The)

ACRV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACRV has been loosely correlated with ALLR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ACRV jumps, then ALLR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACRV
1D Price
Change %
ACRV100%
+2.09%
ALLR - ACRV
48%
Loosely correlated
+1.90%
AURA - ACRV
38%
Loosely correlated
-0.17%
CRBU - ACRV
36%
Loosely correlated
-1.16%
LXEO - ACRV
34%
Loosely correlated
-2.94%
DNTH - ACRV
34%
Loosely correlated
-3.06%
More

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with CRSP. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
-1.16%
CRSP - CRBU
58%
Loosely correlated
-2.87%
BEAM - CRBU
53%
Loosely correlated
-0.57%
RXRX - CRBU
52%
Loosely correlated
-3.41%
SYRE - CRBU
51%
Loosely correlated
-0.33%
AXON - CRBU
50%
Loosely correlated
-1.24%
More